Nuclear bcl10 expression characterizes a group of ocular adnexa MALT lymphomas with shorter failure-free survival
Open Access
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 19 (8) , 1055-1067
- https://doi.org/10.1038/modpathol.3800597
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysisBlood, 2005
- T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphomaLeukemia, 2005
- Expression of the bcl‐6 and MUM1/IRF4 proteins correlate with overall and disease‐specific survival in patients with primary cutaneous large B‐cell lymphoma: a tissue microarray studyJournal of Cutaneous Pathology, 2005
- Characterization of Bcl10 as a potential transcriptional activator that interacts with general transcription factor TFIIBBiochemical and Biophysical Research Communications, 2004
- Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT typeBlood, 2003
- Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphomaBlood, 2003
- Cell cycle deregulation in B-cell lymphomasBlood, 2003
- Ocular adnexal lymphoproliferative disease: a series of 73 casesClinical & Experimental Ophthalmology, 2001
- Extranodal lymphomasAnnals of Oncology, 2000
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998